Portable Tuberculosis Test Matches Laboratory Accuracy in Minutes, Study Finds
A study finds the battery-powered MiniDock MTB delivers lab-accurate tuberculosis results from tongue swabs in under 30 minutes.
Read MorePosted by CLP Edit Staff | Apr 30, 2026 | Infectious Diseases, Molecular Diagnostic Analyzers, Molecular Diagnostics |
A study finds the battery-powered MiniDock MTB delivers lab-accurate tuberculosis results from tongue swabs in under 30 minutes.
Read MorePosted by CLP Edit Staff | Apr 30, 2026 | Colorectal, Molecular Diagnostics |
Singular Genomics introduced Direct-Seq technology for in situ sequencing of FFPE samples on its G4X platform and announced the SPOT-Met colorectal cancer study at AGBT 2026, analyzing 1,000 tumors using spatial multiomics.
Read MorePosted by CLP Edit Staff | Apr 29, 2026 | Company News, Dementias & Alzheimer’s, Molecular Diagnostics |
Circular Genomics and Vitazi.ai have formed a partnership to combine AI-driven retinal imaging and blood-based RNA biomarkers for early Alzheimer’s disease detection, aiming to address gaps in early-stage patient identification.
Read MorePosted by CLP Edit Staff | Apr 29, 2026 | Cancer, Company News, Molecular Diagnostics |
ClearNote Health will present data at DDW 2026 showing its Avantect Pancreatic Cancer Test achieved 82.6% sensitivity and 97.5% specificity in patients at elevated risk.
Read MorePosted by CLP Edit Staff | Apr 29, 2026 | Cancer, Company News, Molecular Diagnostics |
CareDx will acquire Naveris for $160 million, adding a Medicare-reimbursed liquid biopsy platform for viral-mediated cancer monitoring to its precision medicine portfolio.
Read More